technetium-tc-99m-medronate and Budd-Chiari-Syndrome

technetium-tc-99m-medronate has been researched along with Budd-Chiari-Syndrome* in 3 studies

Other Studies

3 other study(ies) available for technetium-tc-99m-medronate and Budd-Chiari-Syndrome

ArticleYear
Visualization of collaterals in budd-chiari syndrome with Tc-99m MDP bone scintigraphy and Tc-99m HMPAO-labeled leukocyte scintigraphy.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:3

    Topics: Abdomen; Adult; Budd-Chiari Syndrome; Collateral Circulation; Female; Humans; Leukocytes; Pelvis; Portal System; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Technetium Tc 99m Medronate

2003
Hepatic diphosphonate accumulation secondary to malignant venous obstruction.
    Clinical nuclear medicine, 1994, Volume: 19, Issue:10

    Topics: Adult; Budd-Chiari Syndrome; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Liver; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Neoplastic Cells, Circulating; Radionuclide Imaging; Renal Veins; Technetium Tc 99m Medronate; Vena Cava, Inferior

1994
Technetium-99m-medronate uptake in hepatic necrosis associated with Budd-Chiari syndrome.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:7

    A 99mTc-MDP bone scan performed on a 52-yr-old female for possible bone metastasis revealed prominent hepatic uptake. Subsequently, a 99mTc-SC scan revealed tracer uptake in the caudate lobe with diminished uptake in the remainder of the liver. Further imaging with Doppler ultrasound and hepatic venography confirmed a diagnosis of Budd-Chiari syndrome. Hepatic necrosis, demonstrated on CT imaging, was secondary to Budd-Chiari syndrome and was felt to be the cause of 99mTc-MDP hepatic uptake in this patient.

    Topics: Budd-Chiari Syndrome; Female; Humans; Liver; Middle Aged; Necrosis; Radionuclide Imaging; Technetium Tc 99m Medronate

1992